An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
Coronavirus infection 2019 is considered a modern challenge to the world community. In the absence of vaccines and antivirals, effective and safe medicines are an urgent request from the healthcare system. We have evaluated the medical technologies for COVID-19 which are being examined. The search w...
Saved in:
Main Author: | A. S. Kolbin |
---|---|
Format: | article |
Language: | RU |
Published: |
Sankt-Peterburg : NIIÈM imeni Pastera
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/01eb08e21d814ff0b0dfa1aee6ed1e0c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
by: Alina Kröker, et al.
Published: (2021) -
A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
by: A. Abayomi, et al.
Published: (2021) -
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
by: Qomara WF, et al.
Published: (2021) -
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
by: Panda PK, et al.
Published: (2021) -
Some opportunities for immunotherapy in coronavirus infection
by: V. S. Smirnov, et al.
Published: (2020)